Home Blog Page 2907

Aurzen Redefines Portable Entertainment with BOOM air, a Searchlight-Style Projector Featuring Powerful Built-in Dolby Audio

By
Advertorial Desk
-

The ultra-portable projector boasts a 110° integrated gimbal, Google TV, and real-time focus for effortless big-screen experiences on any surface.

IRVINE, Calif., Aug. 5, 2025 /PRNewswire/ — Aurzen, an innovator in immersive home entertainment, today redefines the portable projector category with the launch of BOOM air. This striking searchlight-style projector packs a powerful audio system and smart TV functionality into a compact, go-anywhere design, eliminating the need for extra speakers or streaming devices.

The BOOM air is engineered for convenience and performance. Its unique form factor is not just for looks—it houses a robust 10W speaker tuned with Dolby Audio, delivering cinematic sound that fills the room without an external soundbar. This integrated design, combined with its ultra-portable size and power bank compatibility, makes it the perfect all-in-one entertainment hub for movie nights, backyard gatherings, or professional presentations.

An All-in-One Design Philosophy

The design of the BOOM air directly addresses a core challenge in the portable projector market: the trade-off between portability and audio quality. By engineering a powerful10W Dolby Audio system directly into the projector’s unique gimbal-style body, Aurzen has created a truly all-in-one entertainment device. This integration ensures that the immersive, room-filling sound matches the quality of the Full HD projection, delivering a complete cinematic experience without the need for additional accessories. The goal is to provide a grab-and-go cinema experience that is intuitive, versatile, and powerful.

Key Features of the Aurzen BOOM air:

  • Point-and-Play Simplicity (110° Gimbal Stand): The integrated 110° gimbal stand allows you to aim the projection anywhere—from the wall to the ceiling—without needing a separate tripod or stack of books. Setup is instant and versatile.
  • Room-Filling Dolby Audio (10W Speaker): Powerful, built-in 10W speaker with Dolby Audio creates a rich, immersive soundscape, eliminating the cost and hassle of external speakers.
  • Smart TV Built-In (Google TV): Enjoy endless entertainment with Google TV, which provides direct access to thousands of apps like Netflix, YouTube, and Disney+, plus seamless voice control via Google Assistant.
  • Crystal-Clear Real-time Focus (ToF): Sophisticated Time-of-Flight (ToF) sensors instantly analyze the projection surface to deliver a perfectly sharp image in seconds, with no manual adjustments needed.
  • Ultimate Portability (Power Bank Ready): A highly efficient design allows BOOM air to be powered by standard USB-C power banks, offering true freedom to watch anywhere, even when you’re off the grid.

Technical Specifications:

  • Brightness: 300 ANSI Lumens
  • Resolution: Native 1080p (Full HD)
  • Screen Size: 40″ to 250″
  • Audio: 10W Speaker with Dolby Audio
  • Smart OS: Google TV
  • Image Correction: Time-of-Flight (ToF) Real-time Focus, Auto Keystone (Vertical & Horizontal)
  • Connectivity: USB-C, HDMI, Wi-Fi, Bluetooth

Pricing and Availability

The Aurzen BOOM air launched on August 4 and is now available on Aurzen.com and Amazon at a suggested retail price of $299.99.

About Aurzen

Aurzen is a global brand dedicated to creating innovative and accessible projection technology. By combining user-centric design, cutting-edge software, and premium audio-visual components, Aurzen aims to transform any space into an immersive entertainment experience. The company’s products are designed for modern lifestyles, offering simplicity, portability, and performance.

For more information, high-resolution images, or to request a review unit, please contact: 
Aurzen
media@aurzen.com
https://aurzen.com/

Envision Energy Achieves Breakthrough in Two-Blade Wind Turbine Technology with Over 500 Days of Stable Operation

By
Advertorial Desk
-

SHANGHAI, Aug. 5, 2025 /PRNewswire/ — Envision Energy, a global leader in green technology, has announced a significant breakthrough in wind power innovation: its next-generation two-blade onshore smart turbine prototype has achieved over 500 days of stable operation, with a remarkable availability rate of 99.3%, MTBT of 2,444 hours, and equivalent full-load hours reaching 3,048 hours per year. Field performance confirms that the two-blade turbine is on par with traditional three-blade machines operating at the same site.

Envision Energy’s Two-Blade Wind Turbine Achieves 500 Days of Stable Operation
Envision Energy’s Two-Blade Wind Turbine Achieves 500 Days of Stable Operation

This turbine is built on Envision’s Model X onshore platform, featuring a modular design and high-speed DFIG (Doubly-Fed Induction Generator) technology with enhanced stability. Designed for high performance, lightweight construction, and system-level efficiency, it offers a competitive integrated energy solution for diversified green power applications.

“By overcoming key technical challenges such as excessive system vibration and load imbalance – barriers that have long held back two-blade designs, Envision has once again redefined wind power innovation by becoming the first in the industry to demonstrate long-term operational verification of a next-generation two-blade turbine.” said Mr. Lou Yimin, Senior Vice President and Chief Product Officer at Envision Energy.

Envision’s journey with two-blade turbine technology began more than a decade ago. In 2012, the company’s Global Innovation Center (GIC) in Denmark successfully developed the “Game Changer” – a 3.6 MW offshore two-blade turbine – becoming one of the first global innovators to pioneer this unconventional design in the heartland of the wind industry. Since the prototype was installed in 2013, Envision has accumulated significant product development and operational know-how, laying the foundation for its new-generation two-blade turbines.

To bring new technology from concept to commercialization, extensive validation is critical. Envision’s two-blade turbine underwent months of rigorous testing and nearly two years of real-world field operation at its smart wind power verification center, backed by a multi-level, full-process, all-condition validation system. Notably, using one of the  industry’s first multi-degree-of-freedom full-system loading test rigs, Envision defined dozens of unique two-blade operating conditions, focusing on critical performance metrics. All parameters were systematically planned, tested, and validated to ensure technological maturity and readiness for commercial deployment.

Envision’s new-generation two-blade turbine offers a fresh alternative to conventional three-blade models, particularly in scenarios where cost efficiency, transportability, and modular deployment are paramount. This breakthrough reaffirms Envision’s leadership in global wind innovation and its commitment to accelerating the transition to net zero through next-generation clean energy technologies.

 

Multiplier Launches ‘Beyond Borders’ Series to Explore the Realities of Global Employment

By
Advertorial Desk
-

The new video series features conversations with global experts and future-of-work influencers on the challenges and opportunities of hiring, scaling, and managing teams across borders.

NEW YORK, Aug. 5, 2025 /PRNewswire/ — With about 74% of employers worldwide struggling to find skilled talent, spanning industries from healthcare to engineering, global hiring has become a necessity. In IT alone, over 90% of organizations are expected to face skills gaps by 2026. To help companies navigate this, Multiplier, the leading global employment platform, has launched Beyond Borders: New York, a new in-person video series featuring candid conversations between Multiplier leaders and influential voices in HR, compliance, payroll, and the future of work.

As companies scale internationally, HR and business leaders must adapt, from compliance to people strategy. Beyond Borders goes beyond today’s challenges to explore what’s next. Across eight episodes, the series explores every angle of global employment through conversations with the people shaping it, from founders and function heads to HR leaders and analysts. Together, they examine pressing issues including the global talent shortage, reimagining HR in the age of AI, and pay equity for women in distributed teams.

“Our goal was to spark grounded, unscripted dialogue between people who approach the same challenges from different angles and rarely get the chance to meet on the same stage,” said Sagar Khatri, CEO and co-founder of Multiplier. “We paired Multiplier executives with voices who approach global employment from the outside in — people who observe, analyze, and shape the trends transforming work.”

Each episode sits at the intersection of insight and experience, pairing tech leaders with HR strategists, product operators with analysts, and company insiders with external observers.

Featured conversations include:

  • Hebba Youssef (Chief People Officer, Workweek) and Sagar Khatri (CEO, Multiplier) on global HR burnout
  • Aman Kidwai (Editor, Newsweek), Rani Molla (Senior Tech Correspondent, Sherwood News), and Amritpal Singh (Co-founder & President of Field Operations, Multiplier) on global hiring as a response to the talent crisis
  • Erin Grau (COO, Charter) and Jen Briede (VP of Client Solutions, Multiplier) on women in the global workplace
  • Jeanne Meister (Future Workplace) and Vamsi Krishna (Co-founder & MD Global HR Compliance & Advisory, Multiplier) on the intersection of AI and HR
  • Pete Tiliakos (Principal Analyst, Strategic Advisor) and Michael Nierstedt (Product Director, Multiplier) on payroll for a borderless workforce
  • Kathryn Minshew (Founder, The Muse) and Sagar Khatri on adopting a global mindset
  • Sarah Reynolds (Analyst, Lighthouse) and Monish Munshi (CMO, Multiplier) on building global brands
  • Vinnie DiAngelo (VP of People Operations & Organizational Effectiveness, TriNet) and Matthew Carr (CRO, Multiplier) on leading high-performing global-first teams

The series is aimed at CHROs, people leaders, founders, and senior decision-makers tasked with scaling internationally and adapting people strategy to a global reality. While Beyond Borders debuts in New York, Multiplier plans to expand the series to other key markets, spotlighting local and global voices tackling the future of work from every angle.

The Beyond Borders New York series is now rolling out on Multiplier’s website, with one episode releasing each week over the next eight weeks. The first episode, on HR burnout, is now live.

END

About Multiplier

Multiplier is a global employment platform for HR leaders and professionals who need an easy, fast, and cost-effective way to onboard, hire, manage and pay the best global talent across 150+ countries. Through its best-in-class EOR, COR, Global Payroll, and compliance technology, plus person-to-person support and hyper-local employee benefits, Multiplier empowers its customers to hire the best global talent and build a world of limitless opportunity.

 

Liaoning Rural Tourism: A Year-Round Vista among Mountains and Seas

By
Advertorial Desk
-

SHENYANG, China, Aug. 5, 2025 /PRNewswire/ — A news report from CRI:

 

 “Peach blossoms blush like dawn clouds, pear flowers gleam as winter’s snow, maple forests blaze in autumn glory, and snowfields stretch beyond the horizon.” Liaoning captivates visitors with an ever-unfolding rural panorama that shifts with the seasons, establishing itself a destination for all-year travel. The province’s cultural and tourism sector maintains its remarkable momentum. From January to June, visitor arrivals surged by 17.81%, with inbound tourists jumping 44.72% year-on-year, nearly half of whom extended their stays to four days or longer.

A Riot of Blooms and Wings in Spring

In late March, Hekou Village in Kuandian County, Dandong dazzled as miles of peach blossoms along the Yalu River burst into pink glory. The “Pear Blossom Avenue” in Beizhen, Jinzhou saw daily foot traffic peak at 50,000. At the Wolong Lake in Kangping and the tidal flats in Yingkou—key stopovers on the East Asian-Australasian Flyway—over 120,000 rare birds, including red-crowned cranes and swans, are spotted in spring.

An Adventure through Waves and Tides in Summer

This July in Changhai County, Dalian, fisherman Wang Zhongmin’s eight seaside rooms were fully reserved even before May Day holiday, and the demand never waned. The Daludao Island in Dandong and the Xingcheng Beach in Huludao rolled out new offerings like sailing and beach glamping.

A Feast of Colors and Harvest in Autumn

Launching in September, a new “Scarlet Leaves & Paddy Crabs” itinerary will link Benxi’s Guanmen Mountain, Panjin’s Red Beach, and its Rice Park. By day, tourists photograph crimson canopies; by night, they steam freshwater crabs.

A Delight of Snow and Ice in Winter

Gongchangling Ski Resort in Liaoyang will debut nighttime slope lighting this winter, with its hot-spring hotels projected at 80% occupancy. Meanwhile, Northeast-style winter markets in Shenyang and Fushun will buzz alongside lunar new year festivities, featuring Benxi’s Shehuo fire dances and Jinzhou’s shadow puppetry.

An official from Liaoning’s Department of Culture and Tourism announced plans to strategically leverage its “coastal landscapes, borderland charm, Liao cultural heritage, and red tourism” assets, curating more national “Four Seasons in the Countryside” premium routes. By 2025, the province aims to hit 100 million rural tourist arrivals annually.

Liaoning Rural Tourism: A Year-Round Vista among Mountains and Seas

By
Advertorial Desk
-

SHENYANG, China, Aug. 5, 2025 /PRNewswire/ — A news report from CRI:

 

“Peach blossoms blush like dawn clouds, pear flowers gleam as winter’s snow, maple forests blaze in autumn glory, and snowfields stretch beyond the horizon.” Liaoning captivates visitors with an ever-unfolding rural panorama that shifts with the seasons, establishing itself a destination for all-year travel. The province’s cultural and tourism sector maintains its remarkable momentum. From January to June, visitor arrivals surged by 17.81%, with inbound tourists jumping 44.72% year-on-year, nearly half of whom extended their stays to four days or longer.

A Riot of Blooms and Wings in Spring

In late March, Hekou Village in Kuandian County, Dandong dazzled as miles of peach blossoms along the Yalu River burst into pink glory. The “Pear Blossom Avenue” in Beizhen, Jinzhou saw daily foot traffic peak at 50,000. At the Wolong Lake in Kangping and the tidal flats in Yingkou—key stopovers on the East Asian-Australasian Flyway—over 120,000 rare birds, including red-crowned cranes and swans, are spotted in spring.

An Adventure through Waves and Tides in Summer

This July in Changhai County, Dalian, fisherman Wang Zhongmin’s eight seaside rooms were fully reserved even before May Day holiday, and the demand never waned. The Daludao Island in Dandong and the Xingcheng Beach in Huludao rolled out new offerings like sailing and beach glamping.

A Feast of Colors and Harvest in Autumn

Launching in September, a new “Scarlet Leaves & Paddy Crabs” itinerary will link Benxi’s Guanmen Mountain, Panjin’s Red Beach, and its Rice Park. By day, tourists photograph crimson canopies; by night, they steam freshwater crabs.

A Delight of Snow and Ice in Winter

Gongchangling Ski Resort in Liaoyang will debut nighttime slope lighting this winter, with its hot-spring hotels projected at 80% occupancy. Meanwhile, Northeast-style winter markets in Shenyang and Fushun will buzz alongside lunar new year festivities, featuring Benxi’s Shehuo fire dances and Jinzhou’s shadow puppetry.

An official from Liaoning’s Department of Culture and Tourism announced plans to strategically leverage its “coastal landscapes, borderland charm, Liao cultural heritage, and red tourism” assets, curating more national “Four Seasons in the Countryside” premium routes. By 2025, the province aims to hit 100 million rural tourist arrivals annually.

 

Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight

By
Advertorial Desk
-

–          13-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of two oral formulations of ASC30, a once-daily tablet, in 125 participants with obesity or overweight.

–         All 125 participants enrolled in just over one month; topline data expected in the fourth quarter of 2025.

HONG KONG, Aug. 5, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces today completion of enrollment in its U.S. 13-week Phase IIa study evaluating ASC30, a small molecule oral GLP-1 receptor (GLP-1R) agonist for the treatment of obesity (NCT07002905). All 125 participants are obese or overweight with at least one weight-related comorbidity.

“We are excited to announce this important milestone, which brings us another step closer to delivering ASC30 as a potential unique and differentiated treatment for obesity,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, “The rapid pace of enrollment of 125 participants in just over one month underscores the unmet medical need for additional treatment options for obesity. We are looking forward to topline data from this Phase IIa study in the fourth quarter 2025. As a small molecule, ASC30 has the potential to offer both once-daily oral and once-monthly subcutaneous injection dosing options for obesity treatment, if approved.”

The Phase IIa study is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability in participants with obesity (body mass index (BMI) ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2 but < 30 kg/m2) with at least one weight-related comorbidity. Two oral formulations of one-daily ASC30 are being evaluated: formulation 1 (ASC30 tablets) and formulation 2 (ASC30 tablets A1). The primary endpoint of the study is the mean percentage body weight change from baseline at Week 13. The 13-week study protocol has a low starting dose of 1 mg of both formulation 1 and formulation 2, with weekly titrations to the desired maintenance doses of 20 mg and 40 mg of formulation 1 or 20 mg, 40 mg and 60 mg of formulation 2.

Both formulations have been evaluated in the oral ASC30 Phase Ia single ascending dose (SAD) study (NCT06680440). Formulation 2 demonstrated a flatter pharmacokinetic profile compared to formulation 1.

ASC30 was discovered and developed in-house at Ascletis as a first and only investigational small molecule GLP-1R biased agonist designed to be dosed once daily orally and once monthly subcutaneously for the treatment of obesity.

About ASC30

ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection administrations. ASC30 is a new chemical entity (NCE), with U.S. and global compound patent protection until 2044 without patent extensions. 

About Ascletis Pharma Inc.

Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) Platform and Ultra-Long-Acting Platform (ULAP), Ascletis has developed multiple drug candidates in-house, including its lead program, ASC30, a small molecule GLP-1R agonist in development as a once-daily oral tablet and once-monthly subcutaneous injection for weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).

To learn more about Ascletis, please visit www.ascletis.com.

Contact：

Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com

 

Precision-Matched Meat Sourcing: The Global Advantage at FHC2025

By
Advertorial Desk
-

SHANGHAI, Aug. 5, 2025 /PRNewswire/ — FHC Shanghai Global Food Trade Show, Asia’s flagship international food trade fair, returns to the Shanghai New International Expo Centre (SNIEC) from November 12-14, 2025.

China’s Visa Policy Opens Doors for Global Meat Commerce

Leveraging China’s expansive visa-free access for 54 nations, FHC2025 presents an unrivaled opportunity for the international meat industry. Suppliers and buyers gain frictionless entry for pivotal 15-day business engagements. Exhibitors enjoy expedited entry with invitations and 24-hour visa-on-arrival at key ports like Shanghai.

Discover the Future of Meat at Asia’s Premier Food Epicenter

Occupying 200,000 sqm, FHC2025 spotlights the meat sector, building on 2024’s resounding success (171,828 trade visitors, 3,000+ global exhibitors). Dedicated showcases from leading meat nations will be unveiled. Expect robust participation from international pavilions representing key players like Brazil, the USA, the EU, and Australia. Witness the convergence of global trends: premium and specialty cuts, sustainable sourcing and traceability solutions, advanced processing technologies, and the booming ready-to-eat/cook segments, all within Shanghai.

Precision-Matched Connections with High-Value Meat Buyers

The globally acclaimed FHC Hosted Buyer Program offers meat suppliers priority access to high-value procurement channels. Participants gain:

Guaranteed High-Impact Meetings: Secure 50+ pre-vetted appointments with premium hotel procurement directors, chain restaurant central kitchen heads, and specialized meat importers.

Direct Access to Decision Makers: Engage F&B association leaders and hospitality group executives face-to-face, slashing negotiation cycles by 60%.

Actionable Market Intelligence: Gain critical insights into China’s $150 billion meat market dynamics and evolving import regulations.

VIP Advantage: Enjoy all VIP benefits including access to the VIP Lounge, welcome package and accommodation during the exhibition period (Only for VIP delegations).

Position Your Brand in the Global Meat Arena This November at SNIEC, Shanghai!

Booth Inquiry:
Alex.Ni@imsinoexpo.com
Media Cooperation & Hosted Buyer Program:
Lizzy.Chen@imsinoexpo.com

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

By
Advertorial Desk
-

BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS’s multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types of breast cancer. It will also support the potential development of a bespoke AI-powered predictive model aimed at optimizing outcomes for individuals undergoing treatment for breast cancer.

Derived from cutting-edge computing protocols and trained on one of the most diverse multimodal datasets in healthcare, SOPHiA GENETICS’s AI Factories offer powerful predictive insights for assessing patient prognosis and treatment response. AstraZeneca will utilize SOPHiA GENETICS’s AI Factories to analyze multimodal healthcare data — including genomics, imaging, and clinical data — and generate AI-powered insights to help optimize breast cancer outcomes. The companies will also collaborate on real-world evidence generation in Europe and North America to uncover key drivers of treatment efficacy, address critical knowledge gaps, and enhance clinical decision-making through deeper insights.

“We are proud to deepen our partnership with AstraZeneca through this significant new initiative, which highlights the growing demand for secure, compliant, and scalable real-world AI applications,” said Ross Muken, President of SOPHiA GENETICS. “Our platform is purpose-built to manage complex healthcare data environments, and this collaboration reinforces our shared commitment to driving better patient outcomes through trusted, federated analytics powered by data and AI.”

“At AstraZeneca, a core component of our AI strategy has been rooted in the deployment of frontier AI solutions across oncology clinical development,” said Jorge Reis-Filho, Chief AI and Data Scientist, AstraZeneca. “Fine tuning and augmenting our models with multimodal data – including our own data and the data that will be generated as part of this collaboration – is helping us to generate a more holistic understanding of disease biology and biomarkers to tailor the most effective treatment to patients living with cancer.”

This collaboration reinforces SOPHiA GENETICS’ position as a trusted technology partner and underlines its commitment to advancing global health through federated data analytics and artificial intelligence.

For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on LinkedIn. 

About SOPHiA GENETICS  

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn. 

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact support@sophiagenetics.com to obtain the appropriate product information for your country of residence. 

SOPHiA GENETICS Forward-Looking Statements:  

This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. 

 

1...2,9062,9072,908...6,562Page 2,907 of 6,562